Evidence map›Paper›PMID 27941919›Full record

ArticleScientific reports2016

Multiplex CRISPR/Cas9-based genome engineering enhanced by Drosha-mediated sgRNA-shRNA structure.

Qiang Yan, Kun Xu, Jiani Xing, Tingting Zhang, Xin Wang, Zehui Wei, Chonghua Ren, Zhongtian Liu, Simin Shao, Zhiying Zhang

Abstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Building Blocks of Artificial CRISPR-Based Systems beyond Nucleases.International journal of molecular sciences · 2022
    Review
  3. Article
  4. Article
  5. Genome Editing in Cereals: Approaches, Applications and Challenges.International journal of molecular sciences · 2020
    Review
  6. Review
  7. Article
  8. Daisy-chain gene drives for the alteration of local populations.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  9. Article
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Qiang YanCollege of Animal Science and Technology, Northwest A&F University, Yangling 712100, Shaanxi, China.
Kun XuCollege of Animal Science and Technology, Northwest A&F University, Yangling 712100, Shaanxi, China.
Jiani XingCollege of Animal Science and Technology, Northwest A&F University, Yangling 712100, Shaanxi, China.
Tingting ZhangInstitute of applied biology, Shanxi University, 030006, Shanxi, China.
Xin WangCollege of Animal Science and Technology, Northwest A&F University, Yangling 712100, Shaanxi, China.
Zehui WeiCollege of Animal Science and Technology, Northwest A&F University, Yangling 712100, Shaanxi, China.
Chonghua RenCollege of Animal Science and Technology, Northwest A&F University, Yangling 712100, Shaanxi, China.
Zhongtian LiuCollege of Animal Science and Technology, Northwest A&F University, Yangling 712100, Shaanxi, China.
Simin ShaoCollege of Animal Science and Technology, Northwest A&F University, Yangling 712100, Shaanxi, China.
Zhiying ZhangCollege of Animal Science and Technology, Northwest A&F University, Yangling 712100, Shaanxi, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The clustered regularly interspaced short palindromic repeats (CRISPR) system has recently been developed into a powerful genome-editing technology, as it requires only two key components (Cas9 protein and sgRNA) to function and further enables multiplex genome targeting and homology-directed repair (HDR) based precise genome editing in a wide variety of organisms. Here, we report a novel and interesting strategy by using the Drosha-mediated sgRNA-shRNA structure to direct Cas9 for multiplex genome targeting and precise genome editing. For multiplex genome targeting assay, we achieved more than 9% simultaneous mutant efficiency for 3 genomic loci among the puromycin-selected cell clones. By introducing the shRNA against DNA ligase IV gene (LIG4) into the sgRNA-shRNA construct, the HDR-based precise genome editing efficiency was improved as more than 2-fold. Our works provide a useful tool for multiplex and precise genome modifying in mammalian cells.

Indexed as

CRISPR-Cas SystemsGene EditingHEK293 CellsHumansRibonuclease IIIRNA, Small InterferingDROSHA protein, humanRibonuclease IIIRNA, Small Interfering

Identifiers

PMID27941919
PMCPMC5150520

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.